Glaricit 250mg Injection 2ml
GLARIZONTO PHARMA PVT LTD
Glaricit 250mg Injection 2ml belongs to a group of medications called 'psychostimulants' used to treat disturbances of consciousness resulting from head injuries, brain operation and acute stage of cerebral infarction (stroke) in adults.
Glaricit 250mg Injection 2ml contains 'Citicoline', which stabilizes cell membranes by increasing phosphatidylcholine and sphingomyelin synthesis and by inhibiting the release of free fatty acids; thereby, it enhances recovery in patients who had their consciousness disturbed by a head injury or any other brain-related problem and who underwent surgery.
In some cases, Glaricit 250mg Injection 2ml may cause injection site reactions, rash, insomnia (inability to sleep), nausea, feeling of warmth, anorexia (loss of appetite), convulsions, transient diplopia (double vision) and dyspnea (shortness of breath). If these side effects persist or worsen, consult your doctor immediately.
Glaricit 250mg Injection 2ml is not recommended to be used in patients with over-functioning of the sympathetic nervous system or who have a history of hypersensitivity to Citicoline. If you are pregnant or breastfeeding, please inform your doctor so that your doctor will weigh the benefits and any potential risks before prescribing it to you. Glaricit 250mg Injection 2ml may cause irregular body movement and double vision; thus, avoid operating machinery or driving after taking this medicine.
Disturbances of consciousness resulting from head injuries, brain operation and acute stage of cerebral infarction (stroke) in adults.
Glaricit 250mg Injection 2ml contains 'Citicoline’, a psychostimulant or nootropic drug used to nourish and minimize damage to the nerve cells in various conditions associated with the brain. It increases the activity of the central nervous system (brain and spinal cord) and regenerates nerve cells by promoting the synthesis of phospholipids in the brain. it improves recovery in patients who had their consciousness disturbed by a head injury or any other brain-related problem and who underwent surgery.
Let your doctor know if you are allergic or hypersensitive to any medicines. Inform your doctor if you are suffering from kidney, liver, or heart diseases. Glaricit 250mg Injection 2ml should not be used in conjunction with meclofenoxate or clophenoxate-containing medications. Notify your doctor about your medical history and medications in order to rule out any potential negative effects.
Drug-drug interactions: Glaricit 250mg Injection 2ml may interact with antiparkinsonian drugs (levodopa, carbidopa) and nootropic drugs (centrophenoxine, meclofenoxate).
Drug-food interactions: No interactions found.
Drug-disease interactions: Inform your doctor if you have hypertonic of the parasympathetic (over-functioning of the sympathetic nervous system).
Avoiding alcohol is recommended to rule out any possibility of side effects.
There are no adequate and well-controlled studies on pregnant women. Please consult your doctor. Your doctor will prescribe only if the benefits outweigh the risks.
There are no adequate and well-controlled studies on nursing mothers. Please consult your doctor. Your doctor will prescribe only if the benefits outweigh the risks.
Glaricit 250mg Injection 2ml may cause irregular body movement and double vision; thus, avoid using machinery or driving.
Let your doctor know if you have a history of liver impairment/disorder. Your doctor will prescribe only if the benefits outweigh the risks.
Let your doctor know if you have had a history of kidney impairment/disorder. In aged patients with impaired renal function, the dose should be adjusted.
Limited information is available. Please consult your doctor.
This item is Not Returnable.
Expires on or after - Sep-23
Acute cerebral infarction (stroke): Stroke, also called cerebrovascular (CVA) stroke, occurs when there is a decreased blood supply to the brain due to the presence of a blood clot or leakage of blood vessels. The decrease in blood supply leads to a decrease in oxygen and nutrients resulting in the death of brain cells. This condition leads to paralysis of the face, arm, or leg, slurred speech, headache, and difficulty walking.
Head trauma: A head injury (head trauma) is any type of injury to the brain, skull, or scalp. This might range from a minor bump or bruise to a severe brain injury. Concussions, skull fractures, and scalp injuries are examples of common head injuries. The effects and therapies vary widely depending on what caused the head trauma and its severity.
Glaricit 250mg Injection 2ml It stabilises cell membranes by increasing the production of phosphatidylcholine and sphingomyelin and decreasing the release of free fatty acids; as a result, it helps speed up recovery in patients who have had surgery for head injuries or other brain-related conditions.
Glaricit 250mg Injection 2ml can cause insomnia (sleeplessness). However, not everybody taking Glaricit 250mg Injection 2ml experiences this side-effect. If the condition persists or worsens, consult a doctor.
Glaricit 250mg Injection 2ml must not be administered to patients with hypertonic of the parasympathetic (over-functioning of the sympathetic nervous system) or a history of hypersensitivity to Citicoline.
Glaricit 250mg Injection 2ml
HT Road,Out Colony,Sainikpuri, Hyderabad-500094
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.